Words Starting With "T"

Our pre-recorded sounds are fast, clear, and natural, spoken by native speakers.

Thrombectomy

speak

A thrombectomy is a medical intervention in which a blood clot (thrombus) is removed from a blood vessel.

Thrombi

speak

Thrombi (noun) refers to small blood clots that form within blood vessels. They can be loose and free-floating, known as emboli, or attached to the sides of a blood vessel, known as mural thrombi. Thrombi can be a result of the blood's natural clotting process being triggered by injury or damage to a blood vessel, and they can cause a blockage in the flow of blood if they become large enough.

Thrombic

speak

Related to or caused by a blood clot, especially a blood clot that forms in a vein.

Thrombin

speak

Thrombin is a serine protease enzyme that plays a crucial role in the coagulation of blood. It is produced from its inactive precursor, prothrombin, through the action of factor Xa. Once activated, thrombin catalyzes the conversion of fibrinogen into fibrin, which forms the clot that stops bleeding. In the process, thrombin also activates factor XIII to covalently cross-link the fibrin fibers, making the clot stable and dormant.

Thrombinase

speak

Thrombinase is a term that may refer to several enzymes involved in the coagulation cascade, specifically those that activate thrombin.<br><br>In that context, thrombinase can refer to:<br><br>1. Thrombin-like enzymes: These enzymes, such as Factor Xa or Factor IXa, can activate prothrombin to produce thrombin, but they are not identical to thrombin itself.<br>2. Thrombin activators: These are enzymes that can activate thrombin to create a more potent form of thrombin, such as Factor XIa or Factor XIIa.<br>3. Thrombin generation assays: In clinical laboratory settings, thrombin generation assays may refer to the measurement of thrombin generation through the activation of platelets and coagulation factors.<br><br>However, it's worth noting that "thrombinase" is not a commonly used term in the bleeding disorders community, and most people refer to the thrombin-activating cascade as the coagulation cascade or the extrinsic pathway.<br><br>A more accurate term may be "thrombin generating enzyme" or "pro-thrombin activator", relying on the specific enzyme being referenced.

Thrombo-angiitis

speak

Thrombo-angiitis is a medical term that refers to the inflammation of a blood vessel, often due to a combination of inflammation (angiitis) and a blood clot (thrombus). It is a rare condition that can occur in various forms, including thromboangiitis obliterans (Buerger's disease), which affects the arteries and veins in the arms and legs, particularly in smokers.

Thromboangiitis

speak

Thromboangiitis refers to the inflammation of blood vessels due to an abnormality of the blood or an unusual narrowing of the vessels.

Thromboclasis

speak

Thromboclasis is a term that can refer to a phenomenon in the formation of blood clots. It refers to the piercing or disruption of a blood clot, often into the pulmonary artery during the process of a pulmonary embolism.

Thromboclastic

speak

Pertaining to thrombosis (the formation of blood clots) or the breakdown or destruction of cells called thrombocytes (platelets).

Thrombocyte

speak

A thrombocyte, also known as a platelet, is a small blood cell that plays a crucial role in the process of blood clotting. It is a type of cytoplasmic fragment or spherocyte found in the blood. Thrombocytes are produced in the megakaryocytes, a type of bone marrow cell, and are released into the circulation to help stop bleeding when a vessel is injured. They are attracted to the site of an injury, where they aggregate and form a platelet plug to facilitate clotting. Thrombocytes have no nucleus and are rich in various proteins that are essential for initiating blood coagulation, including adhesion, aggregation, and thrombin production. The normal range for this cell type in a healthy individual is approximately 150,000 to 450,000 thrombocytes per microliter of blood.

Thrombocytes

speak

Platelets. A type of blood cell that helps to form blood clots and stop bleeding when a blood vessel is injured.

Thrombocythaemia

speak

A rare blood disorder characterized by an excessive production of platelets (a type of blood cell that helps the blood to clot) in the bone marrow. People with thrombocytosis may be at an increased risk of blood clots and other bleeding complications.

Thrombocythemia

speak

Thrombocythemia is a medical condition characterized by an increased number of platelets in the blood, also known as thrombocytosis. It is a myeloproliferative neoplasm, a group of disorders in which the bone marrow produces too many cells. In thrombocythemia, the bone marrow produces too many platelets, which can lead to an increased risk of blood clots and other bleeding complications.<br><br>There are two main types of thrombocythemia:<br><br>1. Essential thrombocythemia (ET): a benign condition in which the bone marrow produces too many platelets, but it is not caused by another underlying disease.<br>2. Chronic myeloid leukemia (CML): a myeloproliferative neoplasm in which the bone marrow produces too many platelets, white blood cells, and red blood cells.<br><br>Symptoms of thrombocythemia may include:<br><br> Bruising or bleeding easily<br> Dizziness or lightheadedness<br> Shortness of breath<br> Headaches<br> Weakness<br> Pain in the abdomen or bones<br> Petechiae (small red spots on the skin)<br><br>Treatment for thrombocythemia usually involves controlling the platelet count with medications, and in some cases, surgery or radiation therapy may be necessary to remove abnormal bone marrow.

Thrombocytic

speak

Relating to platelets, especially those that cause thrombosis or the formation of blood clots.

Thrombocytopaenia

speak

Thrombocytopaenia, also known as thrombocytopenia, is a condition characterized by an abnormally low level of platelets in the blood. Platelets are small blood cells that play a crucial role in blood clotting and stopping bleeding when a blood vessel is injured.

Thrombocytopaenic

speak

Thrombocytopaenic refers to a medical condition characterized by a low platelet count (thrombocytopenia).

Thrombocytopathy

speak

A thrombocytopenia is a condition characterized by low platelet count below the normal level, with a platelet count below 150,000.

Thrombocytopenia

speak

Thrombocytopenia is a medical condition characterized by an abnormally low level of platelets in the blood. Platelets, also known as thrombocytes, are small blood cells that play a crucial role in blood clotting and preventing bleeding. Thrombocytopenia can cause symptoms such as easy bruising, excessive bleeding, and petechiae (small red or purple spots on the skin).<br><br>Thrombocytopenia can be caused by a variety of factors, including:<br><br>1. Bone marrow problems: Certain medications, chemotherapy, and radiation therapy can damage the bone marrow and reduce platelet production.<br>2. Infections: Certain infections, such as HIV, can suppress the bone marrow and lead to thrombocytopenia.<br>3. Autoimmune disorders: Autoimmune disorders, such as lupus or rheumatoid arthritis, can cause the body to attack and destroy platelets.<br>4. Vitamin deficiencies: Deficiencies in vitamins C and B12 can lead to thrombocytopenia.<br>5. Medication side effects: Certain medications, such as aspirin, heparin, and certain antibiotics, can reduce platelet count.<br><br>Treatment for thrombocytopenia depends on the underlying cause and can include medications, such as corticosteroids or immunoglobulins, to stimulate platelet production, and blood transfusions in severe cases.

Thrombocytopenias

speak

Thrombocytopenias refer to a medical condition characterized by a low platelet count in the blood. Platelets are small cells that play a crucial role in blood clotting and preventing excessive bleeding when a blood vessel is injured. With thrombocytopenia, the body either produces too few platelets or destroys them at an accelerated rate, which can lead to various symptoms such as:<br><br>1. <strong>Increased risk of bleeding:</strong> This is the primary concern with thrombocytopenia. People with low platelet counts are at a higher risk for bleeding issues, especially after surgeries, minor injuries, or certain invasive procedures.<br><br>2. <strong>Petechiae or Purpura:</strong> Spontaneous bleeding into the skin can appear as small red or purple spots (petechiae) and larger areas of bruising (purpura), due to the buildup of blood under the skin that does not clot properly.<br><br>3. <strong>Bruising:</strong> Areas of the skin can bruise more easily and easily than normal, giving the appearance of unexplained bruising.<br><br>4. <strong>Bleeding gums:</strong> Deterioration of the gums, possibly leading to loss of teeth.<br><br>5. <strong>Heavy Menstrual Bleeding:</strong> In women, heavy or prolonged menstrual periods can also be a symptom.<br><br>6. <strong>Easy Epistaxis (Nosebleeds):</strong> Frequent or severe nosebleeds can occur without any apparent cause like a known injury.<br><br>7. <strong>Prolonged Bleeding:</strong> Easy bruising, cuts, or minor wounds that take a long time to stop bleeding can be a sign of low platelet counts.<br><br>Causes of thrombocytopenia include:<br><br>- <strong>Autoimmune disorders:</strong> Conditions like ITP, (immune thrombocytopenic purpura), SLE (systemic lupus erythematosus), and Rheumatoid Arthritis.<br> <br>- <strong>Pregnancy:</strong> The immune system of the mother may recognize the baby's platelets as foreign, leading to antibodies that cause the destruction of baby's platelets.<br> <br>- <strong>Medications:</strong> Certain drugs known as heparin, and acidic medications can interfere with the bone marrow production of platelets.<br> <br>- <strong>Infection:</strong> Certain viral infections, such as HIV or for CVDD drugs became fraught with actual clinical thrombosis in their users.<br> <br>- <strong>Lung Conditions:</strong> CLL (chronic lymphocytic leukemia), or certain cancers that elevate the WI CHE estrogen abdominal sat Drumuele MI NBO reaching

Thrombocytopenic

speak

Thrombocytopenic refers to a medical condition characterized by a low platelet count in the blood, often resulting in an increased risk of bleeding or bruising.

Thrombocytopoiesis

speak

Thrombocytopoiesis refers to the process of forming and developing platelets, which are small blood cells that play a crucial role in blood clotting. It is a complex process that involves the production of platelets from hematopoietic stem cells in the bone marrow, through a series of maturation steps, before they are released into the bloodstream.

Thrombocytosis

speak

Thrombocytosis is a medical condition characterized by an abnormally high platelet count in the blood. Platelets, also known as thrombocytes, are a type of blood cell that plays a crucial role in blood clotting.<br><br>There are two main types of thrombocytosis:<br><br>1. Essential thrombocytosis: Also known as primary thrombocytosis, this is a rare genetic disorder that affects the production of platelets, leading to an unstable platelet count.<br>2. Reactive thrombocytosis: This is a secondary condition that occurs in response to an underlying medical condition, such as an infection, inflammation, trauma, or cancer.<br><br>Symptoms of thrombocytosis may include:<br><br> Headaches<br> Dizziness or lightheadedness<br> Fatigue<br> Bleeding or bruising easily<br> Abdominal pain<br> Joint pain<br><br>If left untreated, thrombocytosis can increase the risk of blood clots, which can lead to serious complications, such as stroke, heart attack, or pulmonary embolism. Treatment typically involves medications that help reduce platelet count and prevent blood clots.

Thromboelastography

speak

Thromboelastography is a medical diagnostic test used to evaluate the viscoelastic properties of blood clotting. It measures the cooperativity of coagulation, or how well the various clotting factors work together to produce a blood clot. The test is based on the principles of rotational tests and measures the change in the physical properties of the clot as it forms.

Thromboembolic

speak

Relating to the formation of a blood clot (thrombus) in a vein or artery that breaks loose and travels to another part of the body, where it can block circulation and cause a serious medical condition, often leading to a stroke or heart attack.

Thromboembolism

speak

A blood clot (thrombus) that breaks loose and travels through the bloodstream until it lodges in a narrower part of a blood vessel, blocking the flow of blood. This condition can occur in the brain, lungs, heart, or other parts of the body and can be life-threatening.

Thromboembolytic

speak

Thromboembolic refers to the formation of a blood clot (thrombus) that breaks loose, travels through the bloodstream, and lodges in another part of the body, causing a blockage (embolism).<br><br>In medical terms, a thromboembolism occurs when a blood clot forms in a vein or an artery and travels through the bloodstream until it gets stuck, blocking normal blood flow to an organ or tissue.<br><br>Examples:<br><br> Pulmonary embolism: a blood clot in the lungs<br> Cerebral embolism: a blood clot in the brain<br> Deep vein thrombosis (DVT): a blood clot in the deep veins of the legs

Thrombogenesis

speak

Thrombogenesis refers to the formation or creation of a blood clot. It's a crucial process in the body, but excessive or abnormal thrombogenesis can lead to various health issues such as cardiovascular diseases, strokes, and pulmonary embolism.

Thrombogenic

speak

Thrombogenic refers to the tendency of a substance, surface, or event to induce the formation of a blood clot (thrombus). In other words, it's the capacity to promote the creation of a blood clot, which can lead to blockages in blood vessels and potentially cause serious health problems, such as thrombosis or ischemia. This term is often used in medical and biomedical contexts to describe materials, devices, or situations that may increase the risk of blood clotting.

Thrombogenicity

speak

The term "thrombogenicity" refers to the tendency of a substance or material to promote the formation of thrombi (blood clots) or thrombosis, i.e., the process of blood clotting. In medical and scientific contexts, thrombogenicity is often discussed in terms of the risk of venous or arterial thrombosis, and is associated with various factors such as materials, devices, and drugs that may interact with the blood coagulation cascade.<br><br>In a broader sense, thrombogenicity can also refer to the ability of a material to cause blood clotting or thrombosis in a biological system, such as a wound or an implant.

Thrombokinase

speak

Thrombokinase is an enzyme involved in the process of blood clotting. It activates prothrombin, a protein in the blood, to form thrombin, which then converts fibrinogen into fibrin to form blood clots.

Thrombolic

speak

The word "thrombolic" refers to a substance or agent that promotes the formation of blood clots (thrombi) or contributes to thrombosis, which is the process of blood clotting. This term is often used in medical contexts.<br><br>There are two main types of thrombolic agents:<br><br>1. Thrombolytic agents: These are substances that dissolve existing blood clots, such as alteplase or streptokinase, which are used to treat acute ischemic stroke, pulmonary embolism, and myocardial infarction.<br>2. Thrombogenic agents: These are substances that increase the tendency of blood to clot, such as those found in certain medical devices or materials that may come into contact with the bloodstream.<br><br>In both cases, thrombolic refers to the promotion of thrombosis, either by dissolving or forming blood clots.

Thrombolysis

speak

Thrombolysis is the medical or chemical breakdown (or dissolution) of blood clots.

Thrombolytic

speak

Thrombolytic refers to the breakdown or dissolving of blood clots, particularly those that occur in the cardiovascular system.

Thrombolytics

speak

Thrombolytics refer to a type of medication or therapy that helps to dissolve blood clots (thrombi) that have formed in the blood vessels, such as in cases of deep vein thrombosis, pulmonary embolism, or stroke.

Thrombomodulin

speak

Thrombomodulin is a protein that plays a critical role in the regulation of blood coagulation. It is a thrombin receptor located on the surface of endothelial cells that help regulate the activity of thrombin, a key enzyme in the coagulation cascade.<br><br>Thrombomodulin binds to thrombin and alters its activity, promoting the activation of protein C, which in turn helps to prevent excessive blood clotting. It also blocks the activation of factor X, which is a crucial step in the coagulation cascade.<br><br>In addition, thrombomodulin has anti-thrombotic properties, meaning it helps to prevent the formation of blood clots and thrombi. It also has anti-inflammatory effects and helps to regulate the immune response.<br><br>Overall, thrombomodulin is an important regulator of the coagulation cascade and helps to maintain normal blood clotting and prevent excessive clot formation.

Thrombopenia

speak

Thrombopenia is a term that refers to a medical condition characterized by a low platelet count in the blood. Platelets, also known as thrombocytes, are small cell-like components in the blood that play a crucial role in blood clotting, which helps to stop bleeding when a blood vessel is injured. bình